Cargando…

Impact of Pre-Analytical Conditions on the Antigenicity of Lung Markers: ALK and MET

Diagnostic assays for molecular alterations highly correlated with prognosis, predictive efficacy or safety of therapeutics are valuable clinical tools and in some cases approved as companion diagnostics (CDx) by the Federal Food and Drug Administration. For example, assays that determine echinoderm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Rachel, Thorne-Nuzzo, Trish, Loftin, Isabell, McElhinny, Abigail, Towne, Penny, Clements, June
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253184/ https://www.ncbi.nlm.nih.gov/pubmed/30724750 http://dx.doi.org/10.1097/PAI.0000000000000730

Ejemplares similares

Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1
por: McElhinny, Abigail S., et al.
Publicado: (2002)

Nebulin regulates the assembly and lengths of the thin filaments in striated muscle
por: McElhinny, Abigail S., et al.
Publicado: (2005)

Basic research opportunities focused on bio-based and bio-inspired materials and potential applications
por: Nick McElhinny, Stephanie A., et al.
Publicado: (2014)

Newly Diagnosed Multiple Sclerosis Presenting as Brown-Séquard Syndrome: A Case Report
por: Hoebee, Shelby, et al.
Publicado: (2022)

Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

A specific loop in human DNA polymerase mu allows switching between creative and DNA-instructed synthesis
por: Juárez, Raquel, et al.
Publicado: (2006)

Paleomagnetism: continents and oceans
por: McElhinny, Michael W, et al.
Publicado: (1999)

Myopalladin, a Novel 145-Kilodalton Sarcomeric Protein with Multiple Roles in Z-Disc and I-Band Protein Assemblies
por: Bang, Marie-Louise, et al.
Publicado: (2001)

Analytic Properties of the Longitudinal Beam Transfer Function
por: Towne, N
Publicado: (2001)

The Genetic Drift Inventory: A Tool for Measuring What Advanced Undergraduates Have Mastered about Genetic Drift
por: Price, Rebecca M., et al.
Publicado: (2014)

Crizotinib Exhibits Antitumor Activity by Targeting ALK Signaling not c-MET in Pancreatic Cancer
por: Yan, Hong Hua, et al.
Publicado: (2014)

SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer
por: Papadakis, Andreas I, et al.
Publicado: (2015)

Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR
por: Narayanan, Dilip, et al.
Publicado: (2017)

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
por: Guerreiro Stucklin, Ana S., et al.
Publicado: (2019)

The fidelity of DNA synthesis by yeast DNA polymerase zeta alone and with accessory proteins
por: Zhong, Xuejun, et al.
Publicado: (2006)

Prognostic and predictive markers in glioblastoma and ALK overexpression
por: Kim, Jang-Hee
Publicado: (2021)

Mismatch Repair Balances Leading and Lagging Strand DNA Replication Fidelity
por: Lujan, Scott A., et al.
Publicado: (2012)

Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS
por: Korpanty, Grzegorz J., et al.
Publicado: (2014)

Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition
por: Megiorni, Francesca, et al.
Publicado: (2015)

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression
por: Chen, Rui-Lian, et al.
Publicado: (2018)

EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
por: Colombino, Maria, et al.
Publicado: (2019)

Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC
por: Daniel, Catherine, et al.
Publicado: (2020)

Biology Undergraduates’ Misconceptions about Genetic Drift
por: Andrews, T. M., et al.
Publicado: (2012)

Identification of a Novel Neuropeptide S Receptor Antagonist Scaffold Based on the SHA-68 Core
por: Zarkin, Allison, et al.
Publicado: (2021)

ALK+ Anaplastic Large Cell Lymphoma With Bladder Involvement Presenting as Fever of Unknown Origin: A Case Report and Literature Review
por: Lawrenz, Joshua, et al.
Publicado: (2013)

The potential role of HGF-MET signaling and autophagy in the war of Alectinib versus Crizotinib against ALK-positive NSCLC
por: Huang, Xing
Publicado: (2018)

Genome instability due to ribonucleotide incorporation into DNA
por: Nick McElhinny, Stephanie A., et al.
Publicado: (2010)

Quantitative Assessment Shows Loss of Antigenic Epitopes as a Function of Pre-analytic Variables
por: Bai, Yalai, et al.
Publicado: (2011)

Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer
por: Clavé, Sergi, et al.
Publicado: (2023)

Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK
por: Damm-Welk, Christine, et al.
Publicado: (2016)

Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
por: Chiang, Nai-Jung, et al.
Publicado: (2016)

ALK and NSCLC: Targeted therapy with ALK inhibitors
por: Hallberg, Bengt, et al.
Publicado: (2011)

ALK Inhibitors in the Treatment of ALK Positive NSCLC
por: Khan, Muhammad, et al.
Publicado: (2019)

CMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinib
por: Du, Xue, et al.
Publicado: (2018)

Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on‐target ALK inhibitors in neuroblastoma
por: Tucker, Elizabeth R., et al.
Publicado: (2017)

c-Met as a new marker of cellular senescence
por: Boichuck, Maria, et al.
Publicado: (2019)

The role of Alk-1 and Alk-5 in the mechanosensing of chondrocytes
por: Sanz-Ramos, Patricia, et al.
Publicado: (2014)

Soluble c-Met Is a Reliable and Sensitive Marker to Detect c-Met Expression Level in Lung Cancer
por: Lv, Huilai, et al.
Publicado: (2015)

Devil in the detail: MET overexpression fails as surrogate marker for MET exon 14 splice site mutations in NSCLC
por: Strickland, Matthew R., et al.
Publicado: (2020)

c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer
por: Kang, Chung Hyo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7q0i702a3pdmdkoll60t0dd3n8